Nova One Advisor
Global Ureteral Obstruction Market Size, Share, Forecast Report, 2020-2027

Global Ureteral Obstruction Market Size, Share, Forecast Report, 2020-2027

Status: Published Category: Healthcare Insight Code: 2737 Format: PDF / PPT / Excel

Content

Ureteral obstruction or urinary tract obstruction is a condition of blockage of urine through the urinary tract, which may be complete or partial. In ureteral obstruction the urine may refluxes backward into your kidneys. Ureteral obstruction is curable, but if not treated, can lead to loss of kidney function, sepsis and eventually death. Other severe consequences are kidney stones, and infection of the urinary tract. Mild symptoms generally in partial blockage are pain on one side, abnormal urine flow and frequent , acute stinging pain etc. Ureteral obstruction are caused by injuries such as a pelvic fracture, ureter, kidneys, bladder or colon cancers, kidney stones in ureter etc. Nervous system disorders in which nerves responsible for bladder control cease to function properly, also cause obstructive uropathy. Some drugs such as those used to control overactive bladder can also cause obstructive uropathy. Other causes are enlarged prostate,

The diagnosis of urinary tract obstruction are ultrasound, bladder catheterization, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), voiding cystourethrography (VCUG), endoscopy, blood and urine tests etc. The market for ureteral obstruction is driven by factors such as congenital abnormalities, low demand flexibility of the treatment due to serious consequences of the defect, increasing penetration of healthcare etc. The market constraints are cost of the treatment, threat of infection and pain during surgery etc.

Considering all these factors, the market for ureteral obstruction is expected to reach $ 22.5 billion by the end of 2023, this market is projected to growing at a CAGR of ~ 8.5 % during 2017-2023.
Segments:

The global ureteral obstruction market is segmented on the basis of type, diagnosis, treatment, equipment and end users. Based on type, the market has been segmented as acute and chronic. Based on diagnosis, the market has been segmented as ultrasound, bladder catheterization, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), voiding cystourethrography (VCUG), pyelography, endoscopy, blood and urine tests and others. Based on the treatment, the market has been segmented as surgery (ureteral stent, nephrostomy, open laparoscopy, catheterization, robot-assisted laparoscopy, others) and drugs (antibiotics, pain killers, others). Based on the equipment, the market has been segmented as devices (catheters, stents, others) and consumables (diagnostic reagents, urinary sample collectors, others) and others. Based on the end users, the market has been segmented as hospitals and clinics, research, others
Key players of Global Ureteral Obstruction Market:

Key players profiled in the report are C. R. Bard, Inc., Boston Scientific Corporation, Cook Medical Inc., Medline Industries, Inc., Coloplast A/S, DISA Vascular, Terumo Europe NV, Medtronic, Novartis AG, Johnson and Johnson and others.

  • Insight Code: 2737
  • No. of Pages: 250
  • Format: PDF/PPT/Excel
  • Published: July 2020
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034